VSee Health Co-CEO transfers 2.87M shares to company
VSee Health, Inc. director and Co-Chief Executive Officer Milton Chen reported an internal restructuring transaction.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
VSee Health, Inc. director and Co-Chief Executive Officer Milton Chen reported an internal restructuring transaction. On May 31, 2026, he transferred 2,870,069 shares of Common Stock to VSee Health, Inc. as consideration under a Stock Purchase Agreement related to his purchase of all equity securities of VSee Lab, Inc. from the company. Following this transaction, his directly held VSee common stock position was reported as 0 shares.
Insider Trade Summary
Other: 2,870,069 shares
Other
1 txn
Insider
CHEN MILTON
Role
Co-Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock, par value $0.0001 per share | 2,870,069 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock, par value $0.0001 per share — 0 shares (Direct)
Holdings Before and After:
Common Stock, par value $0.0001 per share, 2,870,069 to 0 shares (Direct)
Footnotes (1)
- F1. On May 31, 2026, in connection with the execution that certain Stock Purchase Agreement by and between VSee Health, Inc. ("Company") and Milton Chen ("Mr. Chen") (hereinafter, the "Agreement"), Mr. Chen agreed to transfer 2,870,069 shares of Common Stock to the Company, as consideration for Mr. Chen's purchase of all of the equity securities of VSee Lab, Inc., a Delaware corporation from the Company, in accordance with the terms of the Agreement.
Key Figures
Shares transferred: 2,870,069 shares
Price per share: $0.0000 per share
Shares held after transaction: 0 shares
+1 more
4 metrics
Shares transferred
2,870,069 shares
Common Stock transferred to VSee Health, Inc. on May 31, 2026
Price per share
$0.0000 per share
Reported transaction price for the share transfer
Shares held after transaction
0 shares
Direct common stock holdings of Milton Chen following the transaction
Restructuring shares
2,870,069 shares
Shares classified as restructuring in transaction summary
Key Terms
Stock Purchase Agreement, equity securities, consideration, Other acquisition or disposition, +1 more
5 terms
Stock Purchase Agreement financial
"in connection with the execution that certain Stock Purchase Agreement by and between VSee Health, Inc."
A stock purchase agreement is a legal contract that sets the terms for buying or selling shares, specifying the price, number of shares, how payment is made, and any conditions or promises each side must meet. It matters to investors because it defines who owns what, when ownership changes, and what protections or obligations attach to the deal—think of it as a detailed receipt plus the house rules that determine the financial risks and benefits of the transaction.
equity securities financial
"for Mr. Chen's purchase of all of the equity securities of VSee Lab, Inc."
Equity securities are financial instruments that represent ownership shares in a company, like owning a slice of a pie that gives you a claim on its assets and future profits. They matter to investors because ownership can provide returns through price appreciation and occasional profit distributions, and may include voting power to influence company decisions, so their value reflects the firm’s performance and investor expectations.
consideration financial
"Mr. Chen agreed to transfer 2,870,069 shares of Common Stock to the Company, as consideration for Mr. Chen's purchase"
Other acquisition or disposition financial
"transaction_code_description": "Other acquisition or disposition""
restructuring financial
""restructuringCount": 1, "restructuringShares": 2870069"
Restructuring is a deliberate rearrangement of a company’s operations, finances, or ownership—like reorganizing a cluttered house to run more efficiently—often involving cost cuts, asset sales, debt changes, or staff moves. Investors pay attention because restructuring can improve profitability and free up cash, but it can also signal distress, incur one-time costs, or dilute shareholder value; its success affects future earnings and stock performance.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VSEE Co-CEO Milton Chen report on this Form 4?
Milton Chen reported an internal restructuring transaction, transferring 2,870,069 shares of VSee Health common stock to the company. The transfer served as consideration under a Stock Purchase Agreement connected to his acquisition of all equity in VSee Lab, Inc. from VSee Health.
What is Milton Chen’s reported VSEE common stock holding after this Form 4 transaction?
After the reported transaction, Milton Chen’s directly held VSee Health common stock position is listed as 0 shares. The Form 4 shows the full 2,870,069 shares transferred to the company, leaving no directly reported common stock holdings for him following the transaction.
How is the VSEE Form 4 transaction by Milton Chen classified by the SEC code?
The transaction is coded “J” on the Form 4, described as an “Other acquisition or disposition.” The filing’s transaction summary further characterizes it as a restructuring event, reflecting an internal transfer of shares rather than a typical market buy or sell.
AI-generated analysis. How Rhea-AI works. Not financial advice.
